A sterile, liquid topical tissue adhesive composed of an Octyl blend cyanoacrylate formulation designed for your patient's comfort.
Order Information
Overview
Indicated for the closure of skin wounds, including laparoscopic incisions and trauma-induced lacerations. May be used in conjunction with deep dermal stitches.
Order Information
Code
Description
Shipper Case Quantity
CM001
INDERMIL® flexifuze™* Tissue Adhesive
12
Order Information
Clinical Evidence
Flexible1 - Has been designed to be a flexible adhesive when cured to maintain that flexibility over time1
Microbial Barrier2 - In vitro studies have shown that it will stay in place for 5-8 days acting as an effective physical barrier to microbial penetration as long as the adhesive film remains intact3
Dye free formulation - No Discoloration of Wound Sites4
Allows Patient to Shower Daily5 - After 1 hour and up to 5 to 8 days
High Wound Closure Strength6
* Property of Connexicon Medical Ltd.
† Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties *Bench test results may not necessarily be indicative of clinical performance
1. Purdue Pascoe VOC report, report # J906 (slide 27) b. Report # CMPD-RR-16-009. Study to compare INDERMIL® FlexiFuze™ Topical Tissue Adhesive to competitor tissue adhesives for various properties, as reported by visual examination of product application on samples subject to repeated cyclic mechanical constraints.
2. Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015
3. Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus,Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus
4. Scar Tattooing following the Use of Tissue Adhesive Swan, Marc C. M.R.C.S.; Descamps, Marjanne J. L. M.R.C.S.; Broadhurst, Andrew F.R.C.S.Nurse Pract 2001;13:10-12
5. Testing of Connexicon Adhesive Mixture as an effective barrier against microbial penetration. 2015 *Bench test results may not necessarily be indicative of clinical performance. Clinical studies were not conducted to demonstrate microbial barrier properties and a correlation between microbial barrier properties and a reduction in infection has not been established. Test organisms selected = Staphylococcus aureus, Staphylococcus epidermis, Candida albicans, Escherichia coli, Psuedomonas aeruginosa, MRSA, Vancomycin Resistant Enterococcus
6. Wound Closure Strength testing was carried out in accordance with ASTM F2458-05. Bench test results may not necessarily be indicative of clinical performance